An anticonvulsant medication that is used to treat a variety of nervous system-related conditions. For myelin oligodendrocyte glycoprotein antibody disease (MOGAD)Often referred to as MOGAD, Anti-MOG, MOG Ab+, MOG Antibody Disease, MOG Associated Antibody Disease, MOG positive disease , this is sometimes given to reduce tremors, spasms, seizuresA sudden, temporary disturbance in brain activity that causes changes in behavior, movement, sensation, or consciousness, neuropathyDamage or dysfunction of one or more nerves that typically results in numbness, tingling, muscle weakness and pain in the affected area. pain, and other possible uses.
Related Posts
Global Leaders in MOGAD Research Convened May 14-16, 2026
Leading international clinicians, researchers, advocates, and industry collaborators gathered in Cambridge, Massachusetts, for two major back-to-back MOGAD meetings focused on research priorities, clinical trials, therapeutic
The State of MOGAD Science: Research, Treatments & What’s Next
The State of MOGADOften referred to as MOGAD, Anti-MOG, MOG Ab+, MOG Antibody Disease, MOG Associated Antibody Disease, MOG positive disease Science: What We Learned Together This MOGADOften referred to as MOGAD, Anti-MOG, MOG Ab+, MOG Antibody Disease, MOG Associated Antibody Disease, MOG positive disease Awareness Month, we came together with the Siegel Rare NeuroimmuneA term that refers to the components of the immune system that acts in and affects the central nervous system. Association (SRNA) to host